The acquisition of antiapoptotic properties is one of the essential mechanistic steps in colorectal carcinogenesis and is closely correlated with a loss of chemosensitivity and radiosensitivity. Human ring finger homologous to inhibitor of apoptosis protein type (hRFI) is a newly discovered gene encoding a ring finger domain highly homologous to that of X chromosome -linked inhibitor of apoptosis protein. Immunohistochemistry has revealed that the expression of hRFI increased in transition from normal colorectal mucosas to adenomas and from adenomas to carcinomas, suggesting an essential role in the early stage of colorectal carcinogenesis. However, the function role of hRFI in colorectal carcinoma has not been elucidated. To determine whether hRFI possesses an antiapoptotic function in colorectal cancer cells, HCT116 colorectal cancer cells stably overexpressing hRFI were established. The hRFI transfectant exhibited significant resistance to apoptosis induced by tumor necrosis factor-A or tumor necrosis factor -related apoptosis-inducing ligand compared with control. This antiapoptotic response was associated with decreased activity of caspase-3, -8, and -9. We also established an antisense down-regulation of hRFI, which effectively reversed the antiapoptotic activity of the hRFI transfectant. This confirmed that the antiapoptotic property of the hRFI transfectant was not due to the clonal effect but in fact dependent on hRFI function. In conclusion, hRFI possesses an antiapoptotic function in HCT116 colorectal cancer cells. Considering the progressive increase of hRFI expression in the advance of the colorectal adenoma-carcinoma sequence, hRFI is one of the important players in colorectal carcinogenesis through its effect on apoptosis regulation. [Mol Cancer Ther 2005;4(5):743 -50] 
Introduction
The acquisition of antiapoptotic properties is one of the essential steps in carcinogenesis and correlates with resistance to chemotherapy or radiotherapy, leading to further malignant transformation and poor prognosis (1) . Inhibitor of apoptosis proteins (IAP) are key regulators of apoptosis and have been suggested as important molecules in colorectal carcinogenesis (2 -5) . For example, immunohistochemical analysis has revealed that survivin expression increases progressively in sequence from colorectal adenomas with low dysplasia to those with high dysplasia/carcinoma (6) . Survivin expression also correlates with poor prognosis in colorectal carcinomas (7) . Another immunohistochemical analysis has revealed that nuclear cIAP1 expression correlates with the relative risk of death in sporadic colorectal adenocarcinomas (8) .
Human ring finger homologous to IAP type (hRFI; accession no. AB084914) is a newly discovered gene, which we isolated by means of a two-hybrid yeast screening method using hTID-1, an apoptosis regulator protein, as bait (9 -11) . hRFI encodes a ring finger domain highly homologous to that of X chromosome -linked IAP protein (XIAP), which is the most potent IAP among the IAPs (12, 13) . hRFI also encodes a specific cleavage site targeted by caspase-3 at residues 230 to 233 (11) . These structural evidence support a functional relationship of hRFI to the cell death pathway.
We have shown that hRFI is preferentially expressed in esophageal, gastric, and colorectal cancers, suggesting a possible association between hRFI and the development of digestive tract cancers (14, 15) . Especially in the colorectal adenoma-carcinoma sequence, the expression of hRFI increased in the transition from normal colorectal mucosas to adenomas and from adenomas to carcinomas (15) . This sequential increase of hRFI expression enables us to speculate that hRFI might play an essential role in the early stage of colorectal carcinogenesis, probably related to its effects on antiapoptotic transformation. Indeed, transient transfection of hRFI into HeLa cells resulted in a slight increase of surviving cells after treatment with tumor necrosis factor-a (TNF-a; ref. 11 ). However, the molecular mechanism of the increased survival in hRFI transfectant has not been fully clarified yet, and the effect of hRFI on cellular apoptosis or intracellular caspase activity has not yet been examined.
In this study, therefore, we examined whether hRFI molecule really possessed an antiapoptotic function in colorectal cancer cells and showed that stable overexpression of hRFI significantly inhibited death receptor -mediated apoptosis with decreased activities of caspase-3, -8, and -9 in HCT116 human colorectal cancer cells.
Materials and Methods

Cells and Culture Conditions
All cell lines were obtained from the American Type Culture Collection (Rockville, MD). HCT116 was maintained in McCoy's 5A modified medium (Invitrogen, Carlsbad, CA), and other cell lines were in DMEM (Sigma, St. Louis, MO) supplemented with 10% fetal bovine serum (Sigma), 100 units/mL penicillin, and 100 Ag/mL streptomycin (Life Technologies, Inc., Grand Island, NY) at 37jC in a humidified 5% CO 2 atmosphere.
Establishment of a Stable HCT116 Cancer Cell Line Consistently Expressing the hRFI Protein
The full-length cDNA of hRFI was subcloned into a pcDNA3.1/V5-His vector (Invitrogen) as described previously (11) . Cells were seeded at a density of 1 Â 10 5 /mL in 35 mm dishes 24 hours before transfection. Cultures were then transfected with 2 Ag/mL plasmids using 5 Ag/mL Lipofectin (Invitrogen) in a serum-free Opti-MEM medium (Invitrogen) according to the manufacturer's protocol. Transfectants were incubated for 6 hours at 37jC and after replacement of the complete medium maintained for an additional 48 hours. For stable transfection, cells were trypsinized and incubated in the presence of 1,000 Ag/mL G418 (BD Biosciences, Palo Alto, CA) for 2 to 3 weeks. Individual G418-resistant colonies were isolated and maintained in the presence of G418.
Western Blotting Cells were scraped and lysed for 45 minutes at 4jC in a lysis buffer containing PBS with 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mmol/L phenylmethylsulfonyl fluoride, 0.01 mg/mL aprotinin, and 0.01 mg/mL leupeptin. Cell lysates were cleared by centrifugation. The concentration of protein was determined by the BCA protein assay reagent (Pierce Biomedical Co., Rockford, IL). Aliquots (20 Ag) of whole cell lysates were electrophoresed in 15% Ready Gel J (Bio-Rad, Hercules, CA). Separated proteins were electrophoretically transferred to Hybond enhanced chemiluminescence nitrocellulose membrane (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom) and incubated with the primary antibody overnight at 4jC followed by incubation with a rabbit anti-hRFI polyclonal antibody generated previously (11) , an anti-V5-horseradish peroxidase antibody (Invitrogen), and an anti-h-actin antibody (Sigma). Proteins were detected and visualized with the enhanced chemiluminescence detection system (Amersham Pharmacia Biotech).
Proliferation Assay
Cells were seeded in 96-well plates at a density of 5 Â 10 3 per well and allowed to adhere for 24 hours. Then, the proliferative activity was determined by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt assay (CellTiter 96 Non-Radioactive Cell Proliferation Assay; Promega, Madison, WI) to monitor the number of viable cells according to the manufacturer's instructions. Briefly, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt solution was added at 20 AL/well, and after 3 hours of incubation at 37jC in a humidified 5% CO 2 atmosphere, the conversion of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt to formazan was measured in a plate reader at 490 nm. All experiments were done in triplicate, and the proliferation rate was calculated as the ratio of absorbance under each experimental condition to that of the control nontransfectant.
Flow Cytometry Analysis of Cell Cycle Distribution Bromodeoxyuridine, at a final concentration of 5 Ag/mL, was added to the subconfluent cells, which were incubated for a further 1 hour under the same conditions. Cells were then harvested by trypsinization and fixed with 70% ethanol. After staining with the propidium iodide (PI) and FITC-conjugated anti-bromodeoxyuridine antibody (PROGEN Biotechnik GmbH, Heidelberg, Germany), the percentage of cells in each cell cycle phase was measured using Becton Dickinson FACScan with CellQuest software (Franklin Lakes, NJ). The experiments were independently repeated thrice.
Nuclear Staining Assay Cells were plated 24 hours before the induction of apoptosis. Apoptosis was induced by a combination of TNF-a and cycloheximide. After apoptosis induction, cells were harvested by trypsinization and fixed with 70% ethanol. Fixed cells were treated with 0.5% Tween 20 and stained with 0.5 Ag/mL PI for 15 minutes. Nuclear morphology was examined by fluorescence microscopy.
Flow Cytometry Analysis of Apoptosis Cells were plated at a density of 1 Â 10 5 per well in sixwell plates 24 hours before the induction of apoptosis. Apoptosis was induced by a combination of TNF-a and cycloheximide or TNF-related apoptosis-inducing ligand (TRAIL); then, cells were harvested by trypsinization and double stained with Annexin V-FITC and PI using an Annexin V-FITC Apoptosis Detection kit (BioVision Research Products, Mountain View, CA) according to the manufacturer's protocol. Samples were immediately analyzed with a FACScan flow cytometer with CellQuest software. This method allows a distinction to be made between early (Annexin V-FITC -positive/PI-negative) and late (Annexin V-FITC -positive/PI-positive) apoptosis cells, and the apoptosis rate was defined as the percentage of the Annexin V-FITC -positive rate in apoptosis-induced cells. Assays were done in triplicate.
hRFI Inhibits Apoptosis in Colorectal Cancer
Caspase Activity Assay Cells were plated at a density of 1 Â 10 6 in 10 cm dishes 24 hours before the induction of apoptosis. After TNF-a and cycloheximide treatment, the activity of caspase-3, -8, and -9 was assayed using a caspase-3/CPP32, FLICE/ caspase-8, and caspase-9/Mch6 Colorimetric Assay kit (BioVision Research Products) according to the manufacturer's protocol. Assays were done in triplicate.
Antisense Oligonucleotides Antisense oligonucleotides and controls directed to hRFI have been made available by Biognostik (Gottingen, Germany). Two 18-mer phosphorothioate antisense oligonucleotides (AS1: TCATCTTCTGTGTTTGCT and AS2: GCTCCTGCAAATGCTGAC) and an 18-mer and a 16-mer phosphorothioate control oligonucleotides (C1: ACTACTACACTAGACTAC and C2: GCTCTATGACTCC-CAG) were synthesized.
Delivery of Antisense Oligonucleotides Cells were seeded at a density of 1 Â 10 5 per mL in sixwell plates 24 hours before transfection and were transfected with 1 Amol/L antisense oligonucleotides using Lipofectin according to the manufacturer's protocol. Transfectants were incubated for 6 hours at 37jC and, after replacement of the medium, maintained for an additional 24 hours before each assay.
Results hRFI Was Expressed in All of Eight Human Colorectal Cancer Cell Lines
The expression levels of the hRFI protein in eight different human colorectal cancer cell lines were examined by Western blot analysis using an anti-hRFI antibody. A 46-kDa hRFI protein, whose molecular weight was expected from hRFI amino acid sequence, was expressed in all cell lines at variable levels ( Fig. 1) . Another immunoreactive band was also detected of f60 kDa in all cell lines. The proportion of the two expression levels was variable among the cell lines examined.
Selection of HCT116 Cells Stably Expressing hRFI HCT116 cells exhibited a relatively low level of hRFI expression by Western blot analysis (Fig. 1) , and HCT116 cells are relatively sensitive to TNF-a-induced apoptosis (16) . Therefore, HCT116 cells were considered appropriate for examining the antiapoptotic function of hRFI by means of overexpression in human colorectal cancer cells.
To evaluate the functional role of hRFI in human colon cancer cells, we first established HCT116 cell lines stably overexpressing hRFI. HCT116 cells were transfected with an expression vector containing full-length cDNA of hRFI (HCT116/hRFI cells). After selection in G418, resistant cells were isolated and the relative level of hRFI was determined by Western blot. The Western blot analysis revealed that HCT116/hRFI cells exhibited an increased expression of hRFI compared with control cells transfected with LacZ (HCT116/LacZ cells; Fig. 2 ). The exogenously transfected hRFI with V5-His tag was detected at a larger molecular weight than the native hRFI.
Transfection of hRFI Had No Effect on Cell Proliferation and Cell Cycle Distribution
To determine whether hRFI expression affected cell proliferation, in vitro cell proliferation of HCT116/hRFI and HCT116/LacZ cells was assessed by the proliferation assay. No significant differences in proliferation were shown between these transfectants at 24, 36, 48, 60, or 72 hours after plating (data not shown). Next, we examined whether hRFI expression affected the cell cycle of HCT116/ hRFI and HCT116/LacZ cells. As determined by flow cytometry, no differences were shown in the percentage of each cell cycle distribution between these transfectants (data not shown). These results indicate that hRFI expression does not affect cell proliferation and cell cycle distribution.
Overexpression of hRFI Inhibited Apoptosis Induced byTNF-A TNF-a is a pleiotropic cytokine that can elicit a variety of biological responses, such as induction of differentiation and proliferation, but it causes apoptosis in the presence of cycloheximide (17 -19) . To investigate whether hRFI expression affected TNF-a-induced apoptosis, HCT116/hRFI and HCT116/LacZ cells were treated with 10 ng/mL TNF-a and 1 Ag/mL cycloheximide for 5 hours and subjected to a nuclear staining assay. Nuclear staining with PI revealed that apoptotic cells with typical apoptotic nuclei were fewer in HCT116/hRFI cells than in HCT116/LacZ cells (Fig. 3A) . To quantify the apoptosis rates, HCT116/hRFI and HCT116/LacZ cells were exposed to TNF-a and cycloheximide under various conditions and analyzed for the relative apoptotic rate after double staining with Annexin V-FITC and PI using flow cytometry. As shown in Fig. 3B , control cells exhibited no staining for either Annexin V-FITC or PI, and cells that underwent apoptosis stained positive for Annexin V. As shown in Fig. 3C and D, the apoptosis rate was seen in a dose-and time-dependent manner in both transfectants. However, the apoptosis rate in the HCT116/hRFI cells was significantly decreased compared with those of the HCT116/LacZ cells. The apoptosis rate was approximately three times less in the HCT116/hRFI cells than in HCT116/LacZ at 4 hours after exposure to 10 ng/mL (Fig. 3D) . The difference in apoptosis rate was less prominent, but still statistically significant, at 8 hours after apoptosis induction (P < 0.05, Student's t test).
These results clearly indicate that the overexpression of hRFI inhibited the apoptosis induced by TNF-a and cycloheximide in HCT116 cells.
Overexpression of hRFI Inhibited Apoptosis Induced byTRAIL
To determine whether the antiapoptotic effect of hRFI was specific to TNF-a-induced apoptosis or general to death receptor -mediated apoptosis, those transfectants were exposed to TRAIL under various conditions and assessed for apoptosis induction. As shown in Fig. 4A and B, the apoptosis rate by TRAIL was significantly decreased in the HCT116/hRFI cells. These results clearly indicate that the inhibition of apoptosis by hRFI overexpression is not specific to TNF-a-induced apoptosis but general to death receptor -mediated apoptosis.
hRFI Overexpression Reduced Caspase-3, -8, and -9 Activation
To determine whether the antiapoptotic effect of hRFI was associated with the inhibition of the activation of caspases, we measured the activity of caspase-3, -8, and -9 in HCT116/hRFI and HCT116/LacZ cells after treatment with 10 ng/mL TNF-a and 1 Ag/mL cycloheximide. 
hRFI Inhibits Apoptosis in Colorectal Cancer
Caspase-8 activity in HCT116/hRFI cells was inhibited to the half of that in HCT116/LacZ cells at 2 hours after treatment (Fig. 5A) . At this time point, caspase-9 activity did not exhibit any difference but exhibited similar inhibition at 4 hours after treatment (Fig. 5B) . As shown in Fig. 5C , caspase-3 activation in HCT116/hRFI cells was similarly inhibited to the half of that in HCT116/LacZ cells at 2 hours after treatment, and this inhibition was more prominent at 4 hours.
Antisense-Mediated Down-Regulation of Overexpressed hRFI Reversed Its Antiapoptotic Effect
The difference in apoptosis sensitivity between HCT116/ hRFI and HCT116/LacZ cells might be attributed to the clonal effect acquired through the selection in G418 and not to differences in the hRFI expression level. To exclude this possibility, antisense down-regulation of overexpressed hRFI was done in HCT116/hRFI cells using two antisense (A1 and A2) and two control (C1 and C2) oligonucleotides. Both antisense oligonucleotides effectively down-regulated exogenously overexpressed hRFI in HCT116/hRFI cells at 24 hours after transfection (Fig. 6A) . The expression of hRFI partially recovered at 48 hours but was still downregulated compared with the control. The efficiency of antisense down-regulation was higher in A2 oligonucleotides than in A1. Therefore, the following antisense experiments used A2 and the two control oligonucleotides. HCT116/hRFI and HCT116/LacZ cells were exposed to the indicated concentrations of TAIL for 4 h (A) or to 100 ng/mL TRAIL for the indicated durations (B) and analyzed with a flow cytometer for the apoptosis rate after double staining with Annexin V-FITC and PI. Columns, mean of triplicate values; bars, SD. *, P < 0.05; **, P < 0.01, compared with the control by Student's t test. Cells were plated at a density of 1 Â 10 6 in 10 cm dishes 24 h before the induction of apoptosis. After treatment with 10 ng/mL TNF-a and 1 Ag/mL cycloheximide for the indicated durations, the activity of caspase-8 (A), caspase-9 (B), and caspase-3 (C) was assayed using a FLICE/caspase-8, caspase-9/Mch6, and caspase-3/CPP32 colorimetric assay kit, respectively. Columns, mean of triplicate values; bars, SD. *, P < 0.05; ***, P < 0.001; ****, P < 0.0001, compared with the control by Student's t test. To determine whether antisense down-regulation of hRFI affected cell proliferation, in vitro cell proliferation was compared by proliferation assay between antisense-treated HCT116/hRFI cells and control cells. No difference was seen at 24, 36, 48, 60, or 72 hours after transfection (data not shown). Thus, antisense down-regulation of hRFI did not influence the cell proliferation.
Antisense Down-Regulation of Overexpressed hRFI Reversed Its Antiapoptotic Effect Finally, we examined whether the down-regulation of overexpressed hRFI reversed the inhibition of apoptosis. HCT116/hRFI cells transfected with AS2 or control oligonucleotides were treated with 30 ng/mL TNF-a and 3 Ag/mL cycloheximide for 6 hours, and the apoptosis rate was analyzed by flow cytometry after double staining with Annexin V-FITC and PI. The apoptosis rate of antisensetreated HCT116/hRFI cells showed a significant increase compared with that of the control (Fig. 6B) . This indicates that the antisense down-regulation of overexpressed hRFI resulted in the recovery of apoptotic sensitivity, confirming the antiapoptotic effect of hRFI in HCT116 cells.
Discussion
In this study, we found that stable overexpression of hRFI in HCT116 human colorectal cancer cells inhibits TNF-ainduced apoptosis with an evidently decreased activity of caspase-3, -8, and -9. We also revealed that overexpression of hRFI inhibits TRAIL-induced apoptosis. These evidence indicate that hRFI overexpression can suppress apoptosis triggered by death receptor signals. Moreover, the antisense down-regulation of hRFI effectively reversed the antiapoptotic effect of hRFI overexpression. This indicates that the antiapoptotic property of the hRFI transfectants is not due to the clonal effect acquired via selection in G418 but is in fact dependent on hRFI function. This is the first report to show that hRFI molecule really elicits an antiapoptotic function in carcinoma cells.
Western blot analysis of eight colorectal cancer cell lines revealed that the hRFI protein was expressed in all of these lines, although the expression levels were variable. This result is also consistent with previous immunohistochemistry findings showing that hRFI is diffusely expressed in colorectal carcinomas (15) . On the other hand, previous multitissue Northern blot analysis has shown hRFI mRNA to be more highly expressed in normal colonic mucosa than in SW480 colorectal carcinoma cells, and this is inconsistent with the immunohistochemical result that hRFI is not expressed in normal colonic mucosa (15) . Interestingly, this discrepancy between mRNA and protein expression levels was likewise observed in other antiapoptotic genes, XIAP, cIAP1, and cIAP2, using various human tumor cell lines and human leukemia samples (20) . These discrepancies suggest the existence of post-transcriptional regulation of the expression, such as different translational mechanisms or different protein turnover rates (20) . Indeed, the existence of translational regulation of XIAP expression has been reported, with the identification of an internal ribosome entry site within the XIAP mRNA (21 -23) .
We found that the time course of caspase-3 and -8 activation preceded that of caspase-9 during the induction of apoptosis. In the extrinsic apoptotic pathway, stimulation of death receptors by extracellular death ligands, such as TNF-a and TRAIL, results in the formation of death-inducing signaling complexes and the activation of caspase-8, initiating the sequentially subsequent cleavage of downstream effector caspases, such as caspase-3 (24) . On the other hand, activation of caspase-8 also results in the cleavage of Bid, which acts as a bridge to a subsequent initiation of the mitochondrial apoptotic pathway, with the release of cytochrome c from mitochondria and the activation of the caspase-9-containing apoptosome complex (25, 26) . The time course of caspase activation 5 per well in six-well plates 24 h before transfection; then, cells were transfected with 2 Amol/L antisense or control oligonucleotides using LipofectAMINE Plus. After 24 h of incubation, cells were exposed to 30 ng/mL TNF-a and 3 Ag/mL cycloheximide for 6 h and analyzed with a flow cytometer for the apoptosis rate after double staining with Annexin V-FITC and PI. Columns, mean of triplicate values; bars, SD. **, P < 0.01, compared with the control by one-way ANOVA.
shown in our study is consistent with the time course of caspase activation in the extrinsic apoptotic pathway followed by interconnection to the mitochondrial apoptotic pathway.
The functional mechanism of caspase inhibition by hRFI is not yet clear. hRFI possesses a ring finger domain homologous to XIAP but lacks a BIR domain (11) . The BIR domain has been shown to be essential for the caspase inhibition and subsequent suppression of apoptosis by the IAP family, whereas the ring finger domain does not seem to be essential for the inhibition of caspase activity by the IAPs (27) , and the function of the ring finger domain is still not well defined (27) . Recent studies have shown that the ring finger is associated with ubiquitin ligase activity, which has also been revealed in the ring finger of the IAPs (28) . For example, the ring finger domain of cIAP2 has been shown to ubiquitinate caspase-3 and -7 in vitro, which are direct targets of binding and inhibition by the IAPs (29) . Although the single ring finger domain of XIAP is unable to inhibit caspase activity by itself, the ring finger domain of XIAP does have the ubiquitin ligase activity, which is responsible for the proteosomal degradation of caspase-3, Smac, and XIAP itself, thus regulating the antiapoptotic effect of XIAP (27, 30 -32) . These previous findings have indicated that ubiquitination by the ring finger domain mediates, at least in part, the apoptosis regulation by IAP family. In the present study, overexpression of hRFI resulted in a marked inhibition of caspase-3, -8, and -9 activity during apoptosis in HCT116 cells. Considering that the ring finger domain of hRFI possesses a strong homology to that of XIAP, because 22 of the 53 XIAP ring finger residues are identical, this result suggests a possible relationship between hRFI and the ubiquitin ligase activity targeted to caspases, Smac, and XIAP (11) .
In conclusion, hRFI overexpression in HCT116 certainly inhibits death receptor -mediated apoptosis with decreased activities of caspase-3, -8, and -9, and this inhibition is effectively reversed by antisense down-regulation. Considering the progressive increase of hRFI expression in the colorectal adenoma-carcinoma sequence, hRFI is evidently one of the important players in colorectal carcinogenesis through its effect on the regulation of apoptosis. Because apoptosis is closely associated with chemosensitivity and radiosensitivity, hRFI might be a new predictive marker for chemotherapy and a novel therapeutic target for gene therapy in colorectal carcinomas, as in the case of survivin (1, 33) .
